â‚©
3135.00
Nov 29
Business Description
Nexturnbioscience Co Ltd
ISIN : KR7089140008
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.38 | |||||
Equity-to-Asset | 0.59 | |||||
Debt-to-Equity | 0.57 | |||||
Debt-to-EBITDA | -4.5 | |||||
Interest Coverage | 0.02 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 0.52 | |||||
Beneish M-Score | -1.92 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 35.7 | |||||
3-Year EPS without NRI Growth Rate | -80.5 | |||||
3-Year Book Growth Rate | -0.9 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 23.31 | |||||
9-Day RSI | 32.19 | |||||
14-Day RSI | 38.56 | |||||
6-1 Month Momentum % | 37.5 | |||||
12-1 Month Momentum % | -4.89 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.1 | |||||
Quick Ratio | 1.76 | |||||
Cash Ratio | 1.32 | |||||
Days Inventory | 103.66 | |||||
Days Sales Outstanding | 45.41 | |||||
Days Payable | 34.26 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -13.6 | |||||
Shareholder Yield % | -23.17 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 22.35 | |||||
Operating Margin % | 0.37 | |||||
Net Margin % | -65.9 | |||||
FCF Margin % | -16.65 | |||||
ROE % | -16.24 | |||||
ROA % | -9.4 | |||||
ROIC % | 0.05 | |||||
ROC (Joel Greenblatt) % | -67.02 | |||||
ROCE % | -11.11 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1.04 | |||||
PB Ratio | 0.24 | |||||
Price-to-Tangible-Book | 0.25 | |||||
EV-to-EBIT | -4.24 | |||||
EV-to-EBITDA | -4.71 | |||||
EV-to-Revenue | 2.41 | |||||
EV-to-FCF | -14.88 | |||||
Price-to-Projected-FCF | 0.34 | |||||
Price-to-Median-PS-Value | 0.33 | |||||
Earnings Yield (Greenblatt) % | -23.58 | |||||
FCF Yield % | -16.89 | |||||
Forward Rate of Return (Yacktman) % | 17.97 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Nexturnbioscience Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 35,857.494 | ||
EPS (TTM) (â‚©) | -2675 | ||
Beta | 1.72 | ||
Volatility % | 88.51 | ||
14-Day RSI | 38.56 | ||
14-Day ATR (â‚©) | 407.928468 | ||
20-Day SMA (â‚©) | 3724.25 | ||
12-1 Month Momentum % | -4.89 | ||
52-Week Range (â‚©) | 2505 - 6340 | ||
Shares Outstanding (Mil) | 11.28 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Nexturnbioscience Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Nexturnbioscience Co Ltd Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Nexturnbioscience Co Ltd Frequently Asked Questions
What is Nexturnbioscience Co Ltd(XKRX:089140)'s stock price today?
When is next earnings date of Nexturnbioscience Co Ltd(XKRX:089140)?
Does Nexturnbioscience Co Ltd(XKRX:089140) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |